177 related articles for article (PubMed ID: 24532969)
1. Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
Siva R; Bafadhel M; Monteiro W; Brightling CE; Pavord ID
Int J Chron Obstruct Pulmon Dis; 2014; 9():179-86. PubMed ID: 24532969
[TBL] [Abstract][Full Text] [Related]
2. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.
Simpson JL; Powell H; Baines KJ; Milne D; Coxson HO; Hansbro PM; Gibson PG
PLoS One; 2014; 9(8):e105609. PubMed ID: 25148049
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease.
Asai K; Kobayashi A; Makihara Y; Johnson M
Int J Chron Obstruct Pulmon Dis; 2015; 10():803-11. PubMed ID: 25945045
[TBL] [Abstract][Full Text] [Related]
4. Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.
Bafadhel M; Haldar K; Barker B; Patel H; Mistry V; Barer MR; Pavord ID; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2015; 10():1075-83. PubMed ID: 26089657
[TBL] [Abstract][Full Text] [Related]
5. Bacteria and sputum inflammatory cell counts; a COPD cohort analysis.
Beech AS; Lea S; Kolsum U; Wang Z; Miller BE; Donaldson GC; Wedzicha JA; Brightling CE; Singh D
Respir Res; 2020 Nov; 21(1):289. PubMed ID: 33131502
[TBL] [Abstract][Full Text] [Related]
6. Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.
Zhang M; Li Q; Zhang XY; Ding X; Zhu D; Zhou X
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1487-93. PubMed ID: 20725845
[TBL] [Abstract][Full Text] [Related]
7. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
[TBL] [Abstract][Full Text] [Related]
8. The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
Banerjee D; Honeybourne D; Khair OA
Treat Respir Med; 2004; 3(1):59-65. PubMed ID: 15174894
[TBL] [Abstract][Full Text] [Related]
9. Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.
Brill SE; Law M; El-Emir E; Allinson JP; James P; Maddox V; Donaldson GC; McHugh TD; Cookson WO; Moffatt MF; Nazareth I; Hurst JR; Calverley PM; Sweeting MJ; Wedzicha JA
Thorax; 2015 Oct; 70(10):930-8. PubMed ID: 26179246
[TBL] [Abstract][Full Text] [Related]
10. Reduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals.
Unfried K; Krämer U; Sydlik U; Autengruber A; Bilstein A; Stolz S; Marini A; Schikowski T; Keymel S; Krutmann J
Int J Chron Obstruct Pulmon Dis; 2016; 11():2573-2583. PubMed ID: 27799756
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
12. Sputum
George L; Wright A; Mistry V; Sutcliffe A; Chachi L; Haldar K; Ramsheh MY; Richardson M; van der Merwe R; Martin U; Newbold P; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2019; 14():1177-1185. PubMed ID: 31239655
[TBL] [Abstract][Full Text] [Related]
13. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
14. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
15. Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.
Zeitlin PL; Diener-West M; Callahan KA; Lee S; Talbot CC; Pollard B; Boyle MP; Lechtzin N
Ann Am Thorac Soc; 2017 Feb; 14(2):220-229. PubMed ID: 28006108
[TBL] [Abstract][Full Text] [Related]
16. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
17. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial.
John ME; Cockcroft JR; McKeever TM; Coward WR; Shale DJ; Johnson SR; Thornton JG; Harrison TW; Knox AJ; Bolton CE
Int J Chron Obstruct Pulmon Dis; 2015; 10():211-21. PubMed ID: 25673981
[TBL] [Abstract][Full Text] [Related]
19. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
Trials; 2012 Jun; 13():82. PubMed ID: 22682323
[TBL] [Abstract][Full Text] [Related]
20. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
Rennard SI; Dale DC; Donohue JF; Kanniess F; Magnussen H; Sutherland ER; Watz H; Lu S; Stryszak P; Rosenberg E; Staudinger H
Am J Respir Crit Care Med; 2015 May; 191(9):1001-11. PubMed ID: 25695403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
